HIV-1 Tat interacts with cyclin T1 to direct the P-TEFb CTD kinase complex to TAR RNA

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 63, Issue , 1998, Pages 371-380

  Garber, M E ^a   Wei, P ^a   Jones, K A ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE; RNA POLYMERASE II; TRANSACTIVATOR PROTEIN; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 9; CYCLIN T1; RNA BINDING PROTEIN;

CONFERENCE PAPER; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RNA BINDING; RNA TRANSLATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; VIRUS TRANSCRIPTION; AMINO ACID SEQUENCE; BINDING AFFINITY; CONTROLLED STUDY; DOWNSTREAM PROCESSING; ENZYME ACTIVITY; GEL MOBILITY SHIFT ASSAY; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOPRECIPITATION; MACROPHAGE; PROTEIN DNA INTERACTION; TRANSCRIPTION ELONGATION;

EID: 0032450548     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.1998.63.371     Document Type: Conference Paper

References (35)

1. Aboul-ela F., Karn J., and Varani G. 1995. The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein. J. Mol Biol. 253: 313.
2. Bayer P., Kraft M., Ejchart A., Westendorp M., Frank R., and Rosch P. 1995. Structural studies of HIV-1 Tat protein. J. Mol. Biol. 247: 529.
3. Bohjanen P.R., Colvin R., Puttaraju M., Been M., and Garcia-Blanco M.A. 1996. A small circular TAR RNA decoy specifically inhibits Tat-activated HIV-1 transcription. Nucleic Acids Res. 24: 3733.
4. Chun R.F. and Jeang K.T. 1996. Requirements for RNA polymerase II carboxyl-terminal domain for activated transcription of human retroviruses human T-cell lymphotrophic virus I and HIV-1. J. Biol. Chem. 271: 27888.
5. Churcher M.J., Lamont C., Hamy F., Dingwall C., Green S.M., Lowe A.D., Butler J.G., Gait M.J., and Karn J. 1993. High affinity binding of TAR RNA by the human immunodeficiency virus type-1 Tat protein requires base-pairs in the RNA stem and amino acids flanking the basic region. J. Mol. Biol. 230: 90.
6. Cujec T.P., Cho H., Maldonado E., Meyer J., Reinberg D., and Peterlin B.M. 1997a. The human immunodeficiency virus transactivator Tat interacts with the RNA polymerase II holoenzyme. Mol. Cell. Biol. 17: 1817.
7. Cujec T.P., Okamoto H., Fujinaga K., Meyer J., Chamberlin H., Morgan D.O., and Peterlin B.M. 1997b. The HIV transactivator Tat binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II. Genes Dev. 11: 2645.
8. Cullen B.R. 1998. HIV-1 auxiliary proteins: Making connections in a dying cell. Cell 93: 685.
9. Emerman M. and Malim M. 1998. HIV-1 regulatory/accessory genes: Keys to unraveling viral and host cell biology. Science 280: 1880.
10. Emiliani S., Fischle W., Ott M., Van Lint C., Amelia C.A., and Verdin E. 1998. Mutations in the tat gene are responsible for human immunodeficiency virus type 1 postintegration latency in the U1 cell line. J. Virol. 72: 1666.
11. Finzi D. and Siliciano R.F. 1998. Viral dynamics in HIV-1 infection. Cell 93: 665.
12. Frankel A., Bredt D., and Pabo C. 1988a. Tat protein from human immunodeficiency virus forms a metal-linked dimer. Science 240: 70.
13. Frankel A., Chen L., Cotter R., and Pabo C. 1988b. Dimerization of the tat protein from human immunodeficiency virus: A cysteine-rich peptide mimics the normal metal-linked dimer interface. Proc. Natl. Acad. Sci. 85: 6297.
14. Fujinaga K., Cujec T., Peng J., Garriga J., Price D., Grana X., and Peterlin B.M. 1998. The ability of positive transcription elongation factor factor B to transactivate human immunodeficiency virus transcription depends on a functional kinase domain, cyclin T1, and Tat. J. Virol. 72: 7154.
15. Gait M. and Karn J. 1993. RNA recognition by the human immunodeficiency virus Tat and Rev proteins. Trends Biochem. Sci. 18: 255.
16. Garber M.E., Wei P., KewalRamani V., Mayall T.P., Herrmann C.H., Rice A.P., Littman D.R., and Jones K.A. 1998. The interaction between HIV-1 Tat and human Cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine Cyclin T1 protein. Genes Dev. 12: 3512.
17. Garcia-Martinez L.F., Ivanov D., and Gaynor R.B. 1997. Association of Tat with purified HIV-1 and HIV-2 transcription preinitiation complexes. J. Biol. Chem. 272: 6951.
18. Garriga J., Segura E., Mayol X., Grubmeyer C., and Grana X. 1996. Phosphorylation site specificity of the CDC2-related kinase PITALRE. Biochem. J. 320: 983.
19. Gold M.O., Yang X., Herrmann C.H., and Rice A.P. 1998. PITALRE, the catalytic subunit of TAK, is required for human immunodeficiency virus Tat transactivation in vivo. J. Virol. 72: 4448.
20. Grana X., De Luca A., Sang N., Fu Y., Claudio P., Rosenblatt J., Morgan D., and Giordano A. 1994. PITALRE, a nuclear CDC2-related protein kinase that phosphorylates the retinoblastoma protein in vitro. Proc. Natl. Acad. Sci. 91: 3834.
21. Herrmann C.H. and Rice A.P. 1993. Specific interaction of the human immunodeficiency virus Tat proteins with a cellular protein kinase. Virology 197: 601.
22. _. 1995. Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: Candidate for a Tat cofactor. J. Virol. 69: 1612.
23. Herrmann C.H., Carroll R.G., Wei P., Jones K.A., and Rice A.P. 1998. Tat-associated kinase, TAK, activity is regulated by distinct mechanisms in peripheral blood lymphocytes and promonocytic cell lines. J. Virol. 72: 9881.
24. Ho D.D. 1998. Toward HIV eradication or remission: The tasks ahead. Science 280: 1866.
25. Huang H.-W. and Wang K.-T. 1996. Structural characterization of the metal binding site in the cysteine-rich region of HIV-1 Tat protein. Biochem. Biophys. Res. Commun. 227: 615.
26. Huq I. and Rana T. 1997. Probing the proximity of the core domain of an HIV-1 tat fragment in a tat-TAR complex by affinity cleaving. Biochemistry 36: 12592.
27. Jones K.A. 1997. Taking a new TAK on Tat transactivation. Genes Dev. 11: 2593.
28. Jones K.A. and Peterlin B.M. 1994. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 63:717.
29. Jonsen M., Petersen J., Xu Q.P., and Graves B.J. 1996. Characterization of the cooperative function of inhibitory sequences in Ets-1. Mol. Cell. Biol. 16: 2065.
30. Keen N.J., Churcher M.J., and Karn J. 1997. Transfer of Tat and release of TAR RNA during the activation of the human immunodeficiency virus type-1 transcription elongation complex. EMBO J. 16: 5260.
31. Keen N., Gait M., and Karn J. 1996. Human immunodeficiency virus type-1 Tat is an integral component of the activated transcription-elongation complex. Proc. Natl. Acad. Sci. 93: 2505.
32. Kephart D.D., Marshall N.F., and Price D.H. 1992. Stability of Drosophila RNA polymerase II elongation complexes in vitro. Mol. Cell. Biol. 12: 2067.
33. Ko J. and Prives C. 1996. p53: Puzzle and paradigm. Genes Dev. 10: 1054.
34. Levine A. 1997. p53, the cellular gatekeeper for growth and division. Cell 88: 323.
35. Luo Y., Madore S., Parslow T., Cullen B.R., and Peterlin B.M. 1993. Functional analysis of interactions between Tat and the trans-activation response element of human immunodeficiency virus type 1 in cells. J. Virol. 67: 5617.